Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrating oncolytic viruses in combination cancer immunotherapy
Praveen K. Bommareddy, Megha Shettigar, Howard L. Kaufman
Nature reviews. Immunology (2018) Vol. 18, Iss. 8, pp. 498-513
Closed Access | Times Cited: 562

Showing 1-25 of 562 citing articles:

Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 151-167
Closed Access | Times Cited: 1426
From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)
Volker Schirrmacher
International Journal of Oncology (2018) Vol. 54, Iss. 2, pp. 407-419
Open Access | Times Cited: 1093
The microbiome and human cancer
Gregory D. Sepich‐Poore, Laurence Zitvogel, Ravid Straussman, et al.
Science (2021) Vol. 371, Iss. 6536
Open Access | Times Cited: 878
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fučíková, Oliver Kepp, Lenka Kašíková, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 747
Enhancing cancer immunotherapy with nanomedicine
Darrell J. Irvine, Eric L. Dane
Nature reviews. Immunology (2020) Vol. 20, Iss. 5, pp. 321-334
Open Access | Times Cited: 678
The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano‐Goroff, Allison Betof Warner, Jedd D. Wolchok
Cell Research (2020) Vol. 30, Iss. 6, pp. 507-519
Open Access | Times Cited: 609
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale, Efrat Shema, Sherene Loi, et al.
Nature Medicine (2021) Vol. 27, Iss. 2, pp. 212-224
Closed Access | Times Cited: 567
The Next Decade of Immune Checkpoint Therapy
Padmanee Sharma, Bilal A. Siddiqui, Swetha Anandhan, et al.
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 838-857
Open Access | Times Cited: 544
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Jian Liu, Minyang Fu, Manni Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 473
Optimizing oncolytic virotherapy in cancer treatment
Kevin J. Harrington, Daniel J. Freeman, Elizabeth J. Kelly, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 9, pp. 689-706
Closed Access | Times Cited: 426
Metabolic barriers to cancer immunotherapy
Kristin DePeaux, Greg M. Delgoffe
Nature reviews. Immunology (2021) Vol. 21, Iss. 12, pp. 785-797
Open Access | Times Cited: 381
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
Tianyu Tang, Xing Huang, Gang Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 350
Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications
Young Hun Chung, Hui Cai, Nicole F. Steinmetz
Advanced Drug Delivery Reviews (2020) Vol. 156, pp. 214-235
Open Access | Times Cited: 332
Therapy with oncolytic viruses: progress and challenges
Sophia Z. Shalhout, David M. Miller, Kevin S. Emerick, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 3, pp. 160-177
Closed Access | Times Cited: 280
Clinical landscape of oncolytic virus research in 2020
Nicholas Macedo, David M. Miller, Rizwan Haq, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001486-e001486
Open Access | Times Cited: 273
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo, Binfeng Lu, Zongbi Guo, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 249
Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances
Meijun Zheng, Jianhan Huang, Aiping Tong, et al.
Molecular Therapy — Oncolytics (2019) Vol. 15, pp. 234-247
Open Access | Times Cited: 247
Nanomaterials for T-cell cancer immunotherapy
Ningqiang Gong, Neil C. Sheppard, Margaret M. Billingsley, et al.
Nature Nanotechnology (2021) Vol. 16, Iss. 1, pp. 25-36
Closed Access | Times Cited: 244
Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
Qian Sun, Zhenya Hong, Cong Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 239
Many ways to resistance: How melanoma cells evade targeted therapies
Ines Kozar, Christiane Margue, Sonja Rothengatter, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2019) Vol. 1871, Iss. 2, pp. 313-322
Open Access | Times Cited: 224
STING activation in cancer immunotherapy
Ting Su, Yu Zhang, Kristoffer Valerie, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7759-7771
Open Access | Times Cited: 204
Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors
Anthony K. Park, Yuman Fong, Sang‐In Kim, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 559
Open Access | Times Cited: 196
Turning up the heat on non-immunoreactive tumours: opportunities for clinical development
María Ochoa de Olza, Blanca Navarro Rodrigo, Stefan Zimmermann, et al.
The Lancet Oncology (2020) Vol. 21, Iss. 9, pp. e419-e430
Closed Access | Times Cited: 178
Primary and metastatic peritoneal surface malignancies
Delia Cortés‐Guiral, Martin Hübner, Mohammad Alyami, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 178
An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses
Guan Wang, Xi Kang, Katherine Chen, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 172
Page 1 - Next Page

Scroll to top